MedDataX Logo

Study of Eyes and Attention Deficit (SEAD)

NCT ID: NCT00472511

Last Updated: 2008-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

75 participants

Study Classification

OBSERVATIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Attention-Deficit Hyperactivity Disorder (ADHD) is considered to be one of the most prevalent chronic health conditions in children. It affects between 4% and 12% of young children. A relationship between convergence insufficiency (eye teaming) and ADHD has been shown. However, the effect of ADHD medications on focusing and eye teaming has not been previously investigated. Therefore, the purpose of this study is to determine the effect of ADHD medication on focusing and eye teaming skills.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ADHD Convergence Insufficiency Accommodative Insufficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Best corrected visual acuity of 20/25 in both eyes at distance and near;
* Willingness to wear eyeglasses or contact lenses to correct refractive error, if necessary;
* 500" random dot stereopsis

Exclusion Criteria

* Amblyopia (lazy eye);
* Eye disease
Minimum Eligible Age

7 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ohio State University

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Levelle Jenkins, OD

Role: PRINCIPAL_INVESTIGATOR

Ohio State University

Marjean Kulp, OD, MS

Role: PRINCIPAL_INVESTIGATOR

Ohio State University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2001H0269

Identifier Type: -

Identifier Source: org_study_id